Takeda Pharmaceutical
281 hedge funds and large institutions have $1.06B invested in Takeda Pharmaceutical in 2022 Q4 according to their latest regulatory filings, with 54 funds opening new positions, 72 increasing their positions, 99 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 275 → 281 (+6)
0.24% more ownership
Funds ownership: 4.07% → 4.3% (+0.24%)
27% less repeat investments, than reductions
Existing positions increased: 72 | Existing positions reduced: 99
Holders
281
Holding in Top 10
3
Calls
$39.2M
Puts
$16.1M
Top Buyers
| 1 | +$43.4M | |
| 2 | +$41.7M | |
| 3 | +$38.5M | |
| 4 |
Millennium Management
New York
|
+$19.3M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$4.59M |
Top Sellers
| 1 | -$27.3M | |
| 2 | -$23.5M | |
| 3 | -$14.3M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$10.6M |
| 5 |
Janus Henderson Group
London,
United Kingdom
|
-$7.12M |